Distant metastasis-free survival is significantly lower (COX p value = 0.01819; HR = 0.20(95% CI: 0.05–0.76)) in breast cancer patients with low TRIP12 as compared to high TRIP12 levels in the GSE11121 study (Fig. 1a). Here, TRIP12 is linked to breast cancer.